Xiamen Amoytop Biotech Stock Current Valuation
| 688278 Stock | 73.51 0.41 0.56% |
Valuation analysis of Xiamen Amoytop Biotech helps investors to measure Xiamen Amoytop's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Xiamen Amoytop's price fluctuation is very steady at this time. Calculation of the real value of Xiamen Amoytop Biotech is based on 3 months time horizon. Increasing Xiamen Amoytop's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Xiamen Amoytop is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xiamen Stock. However, Xiamen Amoytop's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 73.51 | Real 62.63 | Hype 73.51 | Naive 74.45 |
The real value of Xiamen Stock, also known as its intrinsic value, is the underlying worth of Xiamen Amoytop Biotech Company, which is reflected in its stock price. It is based on Xiamen Amoytop's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Xiamen Amoytop's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Xiamen Amoytop Biotech helps investors to forecast how Xiamen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xiamen Amoytop more accurately as focusing exclusively on Xiamen Amoytop's fundamentals will not take into account other important factors: Xiamen Amoytop Biotech Company Current Valuation Analysis
Xiamen Amoytop's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Xiamen Amoytop Current Valuation | 29.33 B |
Most of Xiamen Amoytop's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xiamen Amoytop Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Xiamen Amoytop Biotech has a Current Valuation of 29.33 B. This is 104.2% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is 76.42% lower than that of the firm.
Xiamen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xiamen Amoytop's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xiamen Amoytop could also be used in its relative valuation, which is a method of valuing Xiamen Amoytop by comparing valuation metrics of similar companies.Xiamen Amoytop is currently under evaluation in current valuation category among its peers.
Xiamen Fundamentals
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.22 | ||||
| Profit Margin | 0.29 % | ||||
| Operating Margin | 0.39 % | ||||
| Current Valuation | 29.33 B | ||||
| Shares Outstanding | 406.8 M | ||||
| Shares Owned By Insiders | 67.08 % | ||||
| Shares Owned By Institutions | 16.64 % | ||||
| Price To Book | 13.21 X | ||||
| Price To Sales | 11.52 X | ||||
| Revenue | 2.1 B | ||||
| Gross Profit | 1.53 B | ||||
| EBITDA | 911.2 M | ||||
| Net Income | 554.35 M | ||||
| Total Debt | 4.16 M | ||||
| Book Value Per Share | 5.57 X | ||||
| Cash Flow From Operations | 512.1 M | ||||
| Earnings Per Share | 1.82 X | ||||
| Target Price | 72.51 | ||||
| Number Of Employees | 1.96 K | ||||
| Beta | 0.43 | ||||
| Market Capitalization | 29.9 B | ||||
| Total Asset | 2.36 B | ||||
| Retained Earnings | 955.01 M | ||||
| Working Capital | 936.53 M | ||||
| Net Asset | 2.36 B | ||||
| Last Dividend Paid | 0.41 |
About Xiamen Amoytop Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xiamen Amoytop Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xiamen Amoytop using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xiamen Amoytop Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Xiamen Stock
Xiamen Amoytop financial ratios help investors to determine whether Xiamen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xiamen with respect to the benefits of owning Xiamen Amoytop security.